Binding of Mucin by E. coli from Human Gut


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Cells of E. coli isolates from the gut of healthy volunteers (N=5) and patients with Crohn’s disease (N=5) and laboratory E. coli strain DH5α bound mucin in vitro in similar amounts ranging from 0.02 to 0.12 mg/mg of bacterial dry weight. Binding was evaluated by the decrease in optical absorption of mucin solution at 214 nm after incubation with bacteria. Detailed analysis of mucin binding by one of isolates showed that during incubation of 0.09 mg/ml bacteria in 0.15 M NaCl containing 0.1 mg/ml mucin at 25oC, maximum binding was reached in 30 min, while in the presence of 14 mM α-methyl mannoside, mucin binding decreased by 46% (p<0.05). Confocal microscopy revealed intensive binding of FITC-labeled mucin to the surface of a small number of bacterial cells. Mucin binding did not significantly affect zeta potential of bacteria and their energetic status assessed by ATP content; at the same time, ATP content in the extracellular environment slightly increased.

Об авторах

T. Vakhrusheva

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

Yu. Baikova

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

N. Balabushevich

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

S. Gusev

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

G. Lomakina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Россия, Moscow

E. Sholina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Россия, Moscow

M. Moshkovskaya

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

P. Shcherbakov

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

O. Pobeguts

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Россия, Moscow

E. Mikhal’chik

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Автор, ответственный за переписку.
Email: lemik2007@yandex.ru
Россия, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах